Intaglietta. Oxygen delivery and consumption in the microcirculation after extreme hemodilution with perfluorocarbons. Am J Physiol Heart Circ Physiol 287: H320 -H330, 2004; 10.1152/ajpheart.01166.2003.-The oxygen transport capacity of fluorocarbons was investigated in the hamster chamber window model microcirculation to determine the rate at which oxygen is delivered to the tissue in conditions of extreme hemodilution [hematocrit (Hct) 11%]. Hydroxyethlyl starch (HES 200; 200 kDa molecular mass) was used as a plasma expander for two isovolemic hemodilutions performed with 10% HES 200 until a Hct of 65%. A third step reduced the Hct to 75% of baseline and was performed with either HES 200 or a 60% perfluorocarbon (PFC) emulsion. Comparisons of HES 200-only-hemodiluted animals versus 4.2 g/kg PFC emulsion-hemodiluted animals were made at 21% and 100% normobaric oxygen ventilation. It was found that systemic and microvascular oxygen delivery was 25% and 400% higher in the PFC animals compared with HES 200 animals, respectively, showing that PFCs deliver oxygen to the tissue when combined with hyperoxic ventilation in the present experiments, with no evidence of vasoconstriction or impaired microvascular function. Oxygen ventilation (100%) led to a positive base excess for the PFC group (5.5 Ϯ 2.5 mmol/l) versus a negative balance (Ϫ0.8 Ϯ 1.4 mmol/l) for the HES 200 group, suggesting that microvascular findings corresponded to systemic events. hyperoxia; functional capillary density; oxygen-carrying capacity; blood substitutes; tissue oxygen delivery THE CORRECTION OF BLOOD LOSSES usually begins with the normalization of blood volume. The continued decrease of red blood cell (RBC) concentration is followed by the restoration of oxygen-carrying capacity. To date, this latter phase remains firmly within the purvey of blood transfusion medicine; however, alternative oxygen-carrying volume fluids such as modified hemoglobins (Hbs) and fluorocarbons have emerged in the past decade. Few of these materials have been objectively analyzed in terms of their transport properties at the level of the microscopic blood vessels, where the actual exchange of oxygen takes place, to determine if their properties lead to adequate transport processes at the cellular/tissue level (8).
THE CORRECTION OF BLOOD LOSSES usually begins with the normalization of blood volume. The continued decrease of red blood cell (RBC) concentration is followed by the restoration of oxygen-carrying capacity. To date, this latter phase remains firmly within the purvey of blood transfusion medicine; however, alternative oxygen-carrying volume fluids such as modified hemoglobins (Hbs) and fluorocarbons have emerged in the past decade. Few of these materials have been objectively analyzed in terms of their transport properties at the level of the microscopic blood vessels, where the actual exchange of oxygen takes place, to determine if their properties lead to adequate transport processes at the cellular/tissue level (8) .
Fluorocarbons have been investigated by different approaches that extended to phase 3 clinical trials (9) . These materials carry oxygen, are synthetic, and, in principle, are available in very large quantities at modest costs. This has tantalized investigators, medical practitioners, and business enterprises, because it could, in principle, lead to a convenient, largely available, and pathogen-free oxygen carrier. However, fluorocarbons only become miscible with water when emulsified with phospholipids (derived from egg yolk) and therefore are not completely synthetic. Furthermore, whereas Hb carries oxygen via a reversible chemical reaction, fluorocarbons carry oxygen as a function of their solubility; therefore, at the PO 2 s prevailing in the microcirculation in normoxia their oxygencarrying capacity is limited and only about twice that of plasma, or 10 times less than Hb.
The low oxygen-carrying capacity of fluorocarbons in normoxic tissue can be augmented by exposing the organism to normobaric 100% oxygen, an approach taken in all attempts to produce an oxygen-carrying blood substitute with this material (7, 9) . Fluorocarbons to be used as blood substitutes would presumably be used to remedy blood losses, decreased oxygencarrying capacity, and anemia in conditions of anemic hyperoxia. The superposition of hyperoxia on the changes of circulating fluid composition is a combination of factors whose effect on the transport of oxygen at microcirculation level is not predictable by model analysis and cannot be readily inferred from systemic measurements. Understanding of the consequences of oxygen transport to the tissue by fluorocarbons may be obtained by direct measurements and experimentation of the transport phenomena at the level of the microcirculation.
Considering that fluorocarbons are synthetic, their availability is not dependent on the transfusional blood supply, their potential ease of storage and application, and their inherent lesser cost than Hb-based oxygen-carrying plasma expanders, it would seem desirable to understand their specific mode of action in the microcirculation to determine their efficacy as a blood substitute. To accomplish this, we carried out a basic microvascular analysis of how oxygen is transported in the microcirculation when blood oxygen-carrying capacity is provided by fluorocarbons and hyperoxia in conditions of extreme hemodilution. This modality was used to evidence the underlying physiological reactions, which are not manifested and are otherwise masked by compensatory mechanisms unless the transfusion trigger is significantly exceeded.
MATERIALS AND METHODS
Animal preparation. Investigations were performed with 55-to 65-g golden Syrian hamsters (Charles River Laboratories; Boston, MA). Animal handling and care were provided following the procedures outlined in the National Institutes of Health Guide for the Care and Use of Laboratory Animals (National Research Council, 1996) . The study was approved by the local Animal Subjects Committee.
The hamster chamber window model is widely used for microvascular studies in the unanesthetized state, and the complete surgical technique has been described in detail elsewhere (4) . Briefly, the animal was prepared for chamber implantation with a 50 mg/kg ip injection of pentobarbital sodium anesthesia. After hair removal, sutures were used to lift the dorsal skin away from the animal, and one frame of the chamber was positioned on the animal's back. The chamber consists of two identical titanium frames with a 15-mm circular window. With the aid of backlighting and a stereomicroscope, one side of the skinfold was removed following the outline of the window until only a thin layer of retractor muscle and the intact subcutaneous skin of the opposing side remained. Saline and then a cover glass were placed on the exposed skin held in place by the other frame of the chamber. The intact skin of the other side was exposed to the ambient environment. The animal was allowed at least 2 days for recovery before the preparation was assessed under the microscope for any signs of edema, bleeding, or unusual neovascularization. Barring these complications, the animal was anesthetized again with pentobarbital sodium. Arterial and venous catheters were implanted in the carotid artery (polyethylene-50) and jugular vein (polyethylene-50), respectively, and filled with a heparinized saline solution (30 IU/ml) to ensure patency at the time of experiment. Catheters were tunneled under the skin and exteriorized at the dorsal side of the neck, where they were attached to the chamber frame with tape. Experiment was performed after at least 24 h but within 48 h after catheter implantation.
Inclusion criteria. Experiments were performed between 24 and 48 h after catheter implantation if the chamber presented normal tissue, showed no bleeding or signs of infection, and had normal arteriolar flow. Systemic inclusion parameters were as follows: heart rate (HR) Ͼ 340 beats/min, mean systemic arterial blood pressure (MAP) Ͼ 80 mmHg, hematocrit (Hct) Ͼ 45%, and arterial PO 2 Ͼ 50 mmHg. Animals with signs of inflammation and bleeding in the chamber were excluded from the study.
Blood chemistry and rheology. Arterial blood was collected in heparinized glass capillaries (0.05 ml) and immediately analyzed for PO2, PCO2, base excess (BE), and pH (Blood Chemistry Analyzer 248, Bayer; Norwood, MA). The comparatively low arterial PO2 and high PCO2 of these animals is a consequence of their adaptation to a fossorial environment. Blood samples for viscosity and colloid osmotic pressure measurements were quickly withdrawn from the animal with a heparinized 3-ml syringe at the end of the experiment for immediate analysis or refrigerated for next-day analysis. Blood samples were centrifuged, and colloid osmotic pressure in plasma was measured (model 420, Colloid osmometer, Wescor; Logan, UT). Calibration of the osmometer was made with a 5% albumin solution using a 30-kDa cutoff membrane (Amicon; Danvers, MA) (33) . The viscosity of plasma and whole blood was determined at a shear rate of 160 s Ϫ1 and 37°C in a Dv-IIϩ Viscometer (Brookfield Engineering Laboratories; Middleboro, MA).
Systemic parameters. MAP and HR were continuously recorded (MP 150, Biopac Systems; Santa Barbara, CA). Hct was measured from centrifuged arterial blood samples taken in heparinized capillary tubes (Readacrit Centrifuge, Clay Adams, Division of Becton-Dickinson; Parsippany, NJ). Hb content was determined spectrophotometrically from a single fluid drop (B-Hemoglobin, Hemocue; Stockholm, Sweden) (18) .
Cardiac output measurement. Cardiac output (CO) was measured by a modified thermodilution technique (3) . In a group of n ϭ 8 animals, the animals were randomly assigned to either group.
Microhemodynamic parameters. Detailed mappings were made of the chamber vasculature so that the same vessels studied in control could be followed throughout the experiment. Functional capillaries, defined as capillary segments with a RBC transit of at least a single RBC in a 30-s period (14) , were assessed in 10 successive microscopic fields, totaling a region of 0.46 mm 2 . Observation was done systematically by displacing the microscopic field of view by a field width in 10 successive steps laterally to the observer. Each 200-mlong displacement (when referred to the tissue) was viewed on the video monitor. The first field was chosen by a distinctive anatomic landmark (i.e., large vascular bifurcation) to easily and quickly reestablish the same fields and vessels at each phase of the experiments. Each field had between two and five capillary segments with RBC flow. Functional capillary density (FCD; in cm Ϫ1 , total length of RBC-perfused capillaries divided by the area of the microscopic field of view) was evaluated by measuring and adding the length of capillaries with RBC transit in the field of view. Relative changes in FCD from baseline levels after each intervention are indicative of the extent of capillary perfusion (14) .
Arteriolar and venular blood flow velocity were measured online using the photodiode/cross-correlator system (model 102B, FiberOptic Photo Diode Pickup and Velocity Tracker, Vista Electronics; San Diego, CA) (10). The measured centerline velocity was corrected according to vessel size to obtain the mean RBC velocity (V) (16) . Vessel diameter (D) was measured online (model 908, Digital Video Image Shearing Monitor, Vista Electronics) (11) . Blood flow rate (Q), equal to V times the cross-sectional area of the vessel, was calculated according to Q ϭ V ϫ (D/2) 2 . Wall shear stress (WSS) is defined by the following formula:
where WSR is the wall shear rate given by 8 ϫ VD Ϫ1 and is the plasma viscosity (27) .
Intravascular and extravascular PO 2 measurements. PO2 measurements were made using palladium-porphyrin phosphorescence quenching microscopy (21) based on the relationship between the decay rate of excited palladium-mesotetra(4-carboxyphenyl)porphyrin (Porphyrin Products; Logan, UT) bound to albumin and the PO 2 according to the Stern-Volmer equation (35) . Animals received a slow intravenous injection of 15 mg/kg body wt (10.1 mg/ml) of the phosphorescence dye ϳ10 min before PO 2 measurements, which provided for an adequate signal-to-noise ratio for interstitial PO2 measurements (21) . Simultaneous tissue PO2 measurements using this system and the microelectrode technique have shown nearly identical values (2) . In our system (21), intravascular measurements were made by placing a rectangular optical window within the vessel of interest, the longest side of the rectangle positioned parallel to the vessel wall. Intravascular PO 2 measurements were made in large feeding arterioles, smaller arcading arterioles, large venules, and smaller collecting venules. Tissue PO 2 measurements were made in interstitial regions void of large vessels with a 10 ϫ 10-m optical window to estimate the lowest oxygen level within the chamber (24) . The decay curves were analyzed offline using a standard single-exponential least-squares numerical fitting technique. Resultant time constants were applied to the Stern-Volmer equation to calculate PO 2, where the quenching constant and the phosphorescence lifetime in the absence of oxygen measured are 325 mmHg/s and 600 s, respectively. The phosphorescence decay due to quenching at a specific PO 2 yields a single decay constant, and in vitro calibration is valid for in vivo measurements (13) .
Acute isovolemic hemodilution and experimental groups. Progressive hemodilution to a final systemic Hct level of 25% of baseline was accomplished with three isovolemic exchange steps according to previously described protocol (22) . Briefly, the volume of each exchange-transfusion step was calculated as a percentage of blood volume, estimated as 7% of body weight. An acute anemic state was induced by lowering the systemic Hct by 60% with two steps (exchange levels 1 and 2) of progressive isovolemic hemodilution using the colloid solution [10% 200-kDa hydroxyethyl starch (HES 200)]. Level 1 exchange was 40% of blood volume, and level 2 and 3 exchanges were each 35% of blood volume.
After level 2 exchange, animals were randomly divided into three experimental groups by sorting on a set of random numbers produced in a random ordering scheme (1), and the level 3 exchange was performed: 1) control group, with colloid solution to Hct of 25% of baseline; and 2) perfluorocarbon (PFC) group, with PCF emulsion.
One hour after level 3 exchange (in both groups), the animal's fraction of inspired oxygen (FI O 2 ) was increased from normal (21%) to 100%. At each level of dilution and after FIO 2 was changed, the animal was given a 10-min recovery period before data acquisition. Details of fluid administration and oxygen inspired levels are shown in Fig. 1 .
Fluids. All animals were hemodiluted with 10% HES 200 (Pentaspan, B. Braun, HES 200 in 0.9% sodium chloride). The PCF emulsion (Oxycyte, Synthetic Blood International; Costa Mesa, CA) consisted of a perfluoronated C-10, cyclohexane compound [60% (wt/vol)] emulsion, using egg yolk lecithin as the emulsifier. The nominal diameter of emulsion particles was 0.2 m. Oxycyte was mixed with 20% HES 200 (mean molecular mass 200 kDa and 0.9% sodium chloride) in a proportion of 80% Oxycyte-20% colloidal solution according to Nolte et al. (17) . The increased concentration of HES 200 (relative to level 3 HES 200-only hemodilution) was used to minimize differences due to autotransfusion due to the differences in concentration after level 3 exchange. Rheological and colloid oncotic parameters are given in Table 1 .
Experimental setup. The unanesthetized animal was placed in a tube that restricted movement but did not impede respiration and was given 30 min to adjust before control systemic parameters (MAP, HR, blood gases, and Hct) were measured. The animal was then fixed to the stage of a transillumination intravital microscope (BX51WI, Olympus; New Hyde Park, NY). The tissue image was projected onto a charge-coupled device camera (COHU 4815) connected to a videocassette recorder (AG-7355, JVC) and viewed on a monitor (151 mp, Samsung). Measurements were made using a ϫ40 (LUMPFL-WIR, numerical aperture 0.8, Olympus) water immersion objective. Contrast between RBCs and tissue was enhanced with a BG12 (420 nm) bandpass filter.
Fields of observations and vessels were chosen for study at locations in the tissue where vessels were in sharp focus. The same fields and vessels were used throughout the experiment, allowing for direct comparisons with baseline levels.
In the experimental exchange groups, successive hemodilution was performed after baseline systemic, microvascular, and hemodynamic characterization. After each exchange and ensuing stabilization period, measurements were performed following the schedule shown in Fig. 1 , where exchanges began every hour. Second exchange was begun exactly 1 h after the first exchange. Blood samples were withdrawn from level 3 exchange animals at the end of the experiment for subsequent analysis of viscosity and colloid osmotic pressure. The duration of the experiments was 5 h.
Fluorocrit measurement. Fluorocrit was assessed in the same capillaries used for Hct measurements by centrifugation (Readacrit Centrifuge, Clay Adams) and is given as a percentage, representing the length of PCF emulsion (indicated by the white color) in the centrifuged capillary tube relative to the entire length of the centrifuged whole blood (consisting of subsequent layers of plasma, cells, and PCF emulsion) (7) .
Tissue oxygen supply from microvascular data. Detailed analysis of tissue oxygen supply was made by calculating oxygen consumption using Eq. 2 when PFCs are not present and Eq. 3 when they are
where RBC Hb is the Hb in RBCs expressed as grams per deciliter of blood, ␥ is the oxygen-carrying capacity of Hb at 100% saturation or 1.34 ml O2/g Hb, SA% is the arteriolar oxygen saturation of RBCs, (1 Ϫ Hct) is the fractional plasma volume and converts the equation from per deciliter of plasma to per deciliter of blood, (1 Ϫ Hct Ϫ Fct) is the fractional plasma volume and converts the equation from per deciliter of plasma to per deciliter of blood when PFCs are present, ␣ is the solubility of oxygen in plasma and equal to 3.14 ϫ 10
, ␣pfc is the solubility of oxygen in Oxycyte and equal to 1.7 ϫ 10 Ϫ2 ml O2 ⅐ dl plasma Ϫ1 ⅐ mmHg Ϫ1 , and Q is microvascular flow for each microvessel. The oxygen dissociation curve for hamster RBCs was determined from freshly collected blood (31) .
Data analysis. Results are presented as means Ϯ SD. Data within each group were analyzed using ANOVA for repeated measurements. When appropriate, post hoc analyses were performed with the Tukey multiple-comparison test. For repeated measurements, time-related changes were assessed by ANOVA (SigmaStat 3.0 for Windows 2000, SPSS). Changes were considered statistically significant if P Ͻ 0.05.
RESULTS
A total of 24 animals was studied. Sixteen animals (62.5 Ϯ 6.8 g) entered the microhemodynamic portion of this study, and all animals tolerated the entire hemodilution protocol without visible signs of discomfort. In one of the experiments, the arterial catheter clogged during the implementation of the second step of the hemodilution, and the animal was excluded from the study. The animals were assigned randomly to the following experimental groups: control (n ϭ 8, 62.4 Ϯ 7.8 g) and PFC (n ϭ 8, 62.9 Ϯ 7.4 g).
Systemic and blood gas parameters. Systemic and blood gas parameters for each experimental group are presented in Tables  2 and 3 . There were no statistically significant differences between experimental groups before the exchange protocol. Systemic Hcts after level 1 and 2 exchange were 29.4 Ϯ 1.7% (28.8 Ϯ 1.0% in control and 30.0 Ϯ 2.2% with PFC) and 19.1 Ϯ 1.1% (18.9 Ϯ 0.9% in control and 19.4 Ϯ 1.4% with PFC, P Ͻ 0.05 relative to baseline), respectively. Level 3 control and PFC exchange reduced systemic Hct to 11.1 Ϯ 0.6% and 10.6 Ϯ 0.5%, respectively, which were significantly reduced from baseline (P Ͻ 0.05) but not statistically different from each other. There was no statistically significant difference in Hct or Hb 1 h after level 3 exchange was achieved and after FI O 2 was increased to 100%.
MAP was not changed from baseline after the level 1 exchange in both groups (96 Ϯ 5 mmHg in control and 96 Ϯ 8 mmHg with PFC), but upon level 2 hemodilution with HES 200, MAP fell to 90 Ϯ 3 mmHg in control and 90 Ϯ 11 mmHg with PFC, which was significantly different from baseline (P Ͻ 0.05), respectively. MAP in the level 3 control group fell to 84 Ϯ 2 mmHg (P Ͻ 0.05 vs. baseline) and was even lower in the PFC group, 71 Ϯ 7 mmHg (P Ͻ 0.05 vs. baseline), the difference between groups not being statistically significant. MAP was 83 Ϯ 3 and 83 Ϯ 10 mmHg when FI O 2 was increased to 100%, which was still significantly lower than baseline (P Ͻ 0.05; Fig. 2A) .
HR was not affected by any of the hemodilution protocols in the control group. The PFC group showed increased HR after level 2 and 3 exchange (460 Ϯ 11 and 475 Ϯ 11 beats/min), being significantly higher than baseline (P Ͻ 0.05). Increasing FI O 2 in the PFC group caused no difference with baseline and with the animals in the control group at the same level of dilution (Fig. 2B) .
Systemic arterial blood gas analysis showed (see Table 3 ) a statistically significant (P Ͻ 0.05) rise in PO 2 from baseline with an increasing degree of hemodilution in levels 2 and 3 [76 Ϯ 1 and 89 Ϯ 2 mmHg for the control group and 79 Ϯ 12 and 101 Ϯ 12 mmHg for the PFC group, significantly higher than baseline (P Ͻ 0.05)]. Increasing FI O 2 significantly increased PO 2 [412 Ϯ 12 mmHg in control and 594 Ϯ 18 mmHg with PFC (P Ͻ 0.05 relative to baseline and level 3 exchange)].
PCO 2 was not significantly changed relative to baseline by the hemodilution protocols, whereas the increase of FI O 2 showed a significant rise of PCO 2 in the control group compared with level 3 exchange of the same group (48 Ϯ 3 mmHg, level 3 FI O 2 100%, control, P Ͻ 0.05).
Blood pH was not statistically changed from baseline among all experimental groups except in the control group, which showed a statistically significant decrease when the FI O 2 was increased during level 3 exchange (7.340 Ϯ 0.021, level 3 FI O 2 100%, control, P Ͻ 0.05).
Blood BE was significantly decreased after level 3 hemodilution in both groups compared with baseline (Ϫ2.0 Ϯ 2.7 Values are means Ϯ SD. Baseline included all the animals in the study. No significant differences were detected between the baseline values of each group. Hb, hemoglobin content of blood; Hct, systemic hematocrit; Fct, percentage of PCF emulsion. *Significant different from blood (P Ͻ 0.05). mmol/l in control and Ϫ3.0 Ϯ 1.5 mmol/l with PFC, P Ͻ 0.05). Increasing FI O 2 significantly increased BE in the PFC group to 5.5 Ϯ 2.5 mmol/l (P Ͻ 0.05).
Cardiac output. Eight animals (n ϭ 8, 67.7 Ϯ 5.5 g) entered the CO protocol and tolerated the entire procedure without visible signs of discomfort. The animals were assigned randomly to the following experimental groups: control (n ϭ 4, 68.1 Ϯ 8.9 g) and PFC (n ϭ 4, 66.8 Ϯ 7.4 g). CO increased after level 1 and 2 exchange in both groups, 123 Ϯ 6% (22.1 Ϯ 1.9 ml/min, control level 1, P Ͻ 0.05) and 159 Ϯ 10% (28.6 Ϯ 1.8 ml/min, control level 1, P Ͻ 0.05) for the control group and 151 Ϯ 8% (24.7 Ϯ 1.7 ml/min, control level 1, P Ͻ 0.05) and 169 Ϯ 16% (27.5 Ϯ 1.8 ml/min, control level 1, P Ͻ 0.05) for the PFC group, respectively (Fig. 2C) . CO decreased significantly after level 3 exchange in the control group relative to baseline, 89 Ϯ 4% (16.2 Ϯ 1.9 ml/min in control, P Ͻ 0.05).
Physical properties of blood. Table 4 compares rheological properties and the colloid osmotic pressure of blood after level 3 exchange. Blood and plasma viscosities were significantly different from baseline in the control and PFC groups (P Ͻ 0.05). Blood viscosity was reduced to 2.21 Ϯ 0.34 and 2.67 Ϯ 0.41 cP, and plasma viscosity was increased to 1.29 Ϯ 0.21 and 1.49 Ϯ 0.27 cP, respectively. Colloid osmotic pressure was statistically unchanged, indicating that the control group might be hypervolemic relative to the PFB group, because according to calculations this group received a total 0.52 g of HES 200 versus 0.38 g for the PFB group. However, a major shift of blood volume was not evidenced by the change of Hct, a relatively good indicator of volume shifts in these conditions of extreme hemodilution, which was virtually identical for the two groups.
Microhemodynamics. Diameters of large feeding arterioles, small arcading arterioles (range, 42-96 m), and small collecting venules (range, 40 -70 um) were measured after each hemodilution step. Figure 3A shows that arteriolar diameter was unchanged after level 1 and 2 exchange in both groups. Upon further blood exchange to level 3, control group arterioles contracted to 92 Ϯ 8% (61.8 Ϯ 16.0 m, n ϭ 20, P Ͻ 0.05) of baseline. After FI O 2 was increased, arterioles of the PFC group contracted to 90 Ϯ 17% (64.8 Ϯ 14.0 m, n ϭ 20, P Ͻ 0.05) of baseline.
Venules during hemodilution, shown in Fig. 3D as a function of dilution level, responded to level 1 exchange by constricting to 88 Ϯ 7% (49.5 Ϯ 7.0 m, n ϭ 26, P Ͻ 0.05) of baseline in the control group and 89 Ϯ 9% (51.9 Ϯ 7.6 m, n ϭ 35, P Ͻ 0.05) of baseline in the PFC group. After level 2 exchange, venules remained constricted to 89 Ϯ 13% (50.1 Ϯ 8.6 m, n ϭ 26, P Ͻ 0.05) of baseline in the control group and 93 Ϯ 11% (53.8 Ϯ 8.7 m, n ϭ 35, P Ͻ 0.05) of baseline in the PFC group. Constriction persisted in the PFC group during level 3 exchange and during the FI O 2 increase, to 95 Ϯ 6% (55.2 Ϯ 8.0 m, n ϭ 35, P Ͻ 0.05) and 88 Ϯ 11% (53.0 Ϯ 8.9 m, n ϭ 35, P Ͻ 0.05) of baseline.
RBC velocity and blood flow. Figure 3 shows the change in RBC velocity in arterioles (B) and venules (E) as a function of the hemodilution level. Arteriolar velocity increased after level 1 exchange to 139 Ϯ 8% for the control group (6.5 Ϯ 2.7 mm/s, P Ͻ 0.05) and 147 Ϯ 14% for the PFC group (6.9 Ϯ 1.5 mm/s, P Ͻ 0.05) of baseline, respectively. Venular RBC velocity also increased in both groups after level 1 exchange to 142 Ϯ 9% in the control group (1.6 Ϯ 0.8 mm/s, P Ͻ 0.05) and 130 Ϯ 13% for the PFC group (1.8 Ϯ 0.7 mm/s, P Ͻ 0.05) of baseline in the PFC group.
After level 2 exchange, arteriolar RBC velocity remained elevated relative to baseline for both the control and PFC groups [130 Ϯ 8% for the control group (6.1 Ϯ 2.7 mm/s, P Ͻ 0.05) and 145 Ϯ 13% for the PFC group (6.8 Ϯ 1.7 mm/s, P Ͻ 0.05), respectively]. Conversely, venular RBC velocity returned to baseline levels. Level 3 exchange reduced the arteriolar RBC velocity versus baseline in both groups, being 66 Ϯ 7% for the control group (3.1 Ϯ 1.3 mm/s, P Ͻ 0.05) and 76 Ϯ Arteriolar and venular blood flows after the hemodilution protocols are presented in Fig. 3 . The results are given as means Ϯ SE to show the trend of this parameter calculated from vessel diameter and RBC velocity. Arteriolar blood flow (Fig. 3C ) was statistically increased from baseline after level 1 and 2 exchange to 141 Ϯ 21% (24.6 Ϯ 17.4 l/s, control level 1, P Ͻ 0.05) and 147 Ϯ 27% (24.2 Ϯ 15.7 l/s, control level 2, P Ͻ 0.05) in the control group and 146 Ϯ 30% (28.9 Ϯ 12.1 l/s, PFC level 1, P Ͻ 0.05) and 157 Ϯ 39% (31.0 Ϯ 13.5 l/s, PFC level 2, P Ͻ 0.05) in the PFC group. Venular blood flow (Fig. 3F ) was statistically decreased from baseline after level 2 exchange to 77 Ϯ 25% (2.3 Ϯ 1.5 l/s, P Ͻ 0.05) in the control group and 78 Ϯ 19% (3.0 Ϯ 1.5 l/s, P Ͻ 0.05) in the PFC group. After level 3 exchange, control and PFC groups decreased arteriolar blood flow from baseline to 57 Ϯ 10% (9.6 Ϯ 6.4 l/s in control, P Ͻ 0.05) and 67 Ϯ 23% (12.9 Ϯ 6.0 l/s with PFC, P Ͻ 0.05), respectively. Venular blood flow was significantly decreased from baseline after level 3 exchange and after FI O 2 was increased in the control group to 71 Ϯ 16% (2.1 Ϯ 1.5 l/s, level 3, P Ͻ 0.05) and 71 Ϯ 19% (2.0 Ϯ 1.3 l/s, FI O 2 100%, P Ͻ 0.05), respectively.
WSS. WSS was calculated for each vessel studied after level 3 exchange in control and PFC groups and when FI O 2 was increased (see Fig. 4 ). The calculated values of WSS are The significantly greater wall shear rate found with PFC hemodilution is due to the comparatively higher viscosity and may compensate for the vasoconstrictor effect due to hyperoxia by increasing nitric oxide release from the endothelium. Values are presented as means Ϯ SD. There were significant changes in wall shear stress. §Sig-nificantly different from baseline (P Ͻ 0.05); †significantly different with change in FIO 2 (P Ͻ 0.05); ‡significantly different between fluids (P Ͻ 0.05). presented as means Ϯ SE to show the trend rather than the distribution of the parameter. Before the exchange protocol, there were no statistically significant differences in WSS among the arterioles (control: 7. The venular WSS for the control group decreased relative to baseline to 74 Ϯ 5% (1.50 Ϯ 0.23 dyn/cm 2 , P Ͻ 0.05), and in the PFC group it increased relative to baseline to 142 Ϯ 4% (3.38 Ϯ 0.27 dyn/cm 2 , P Ͻ 0.05). After the increase of FI O 2 , arteriolar and venular WSSs were increased relative to baseline in the PFC group to 123 Ϯ 8% (3.38 Ϯ 0.27 dyn/cm 2 , P Ͻ 0.05) and 154 Ϯ 5% (3.66 Ϯ 0.28 dyn/cm 2 , P Ͻ 0.05), respectively. Increased FI O 2 increased WSS in the venules of the control group relative to baseline to 140 Ϯ 6% (2.12 Ϯ 0.36 dyn/cm 2 , P Ͻ 0.05). There was no significant difference in arteriolar WSS between control and PFC groups after level 3 exchange; however, the level 3 PFC group had a significant increase in WSS relative to the control group in venules (P Ͻ 0.05), and the increase of FI O 2 caused a significant difference in arteriolar and venular WSSs (P Ͻ 0.05).
Functional capillary density. Figure 5 shows the effect of hemodilution on the length of RBC-perfused capillaries per unit area. FCD after level 1 exchange was reduced relative to baseline to 92 Ϯ 5% (P Ͻ 0.05) in the control group and 93 Ϯ 3% in the PFC group (not statistically different from baseline). Level 2 exchange reduced FCD to 84 Ϯ 4% of baseline (P Ͻ 0.05) for the control group and 88 Ϯ 3% of baseline (P Ͻ 0.05) for the PFC group. FCD was further reduced after level 3 exchange in control and PFC groups to 66 Ϯ 4% and 63 Ϯ 10% of baseline, respectively (P Ͻ 0.05). FCD was significantly lower than baseline after the increase of FI O 2 , FCD being 66 Ϯ 5% and 66 Ϯ 7% of baseline in control and PFC groups, respectively (P Ͻ 0.05). No statistical difference was found as a consequence of increase of FI O 2 between groups.
It should be noted that this preparation under normal conditions and during the course of the experimental procedures shows a decrease in FCD of 13% over a period of 6 h. Therefore, the loss in FCD found after level 1 and 2 exchange is near the expected change of this parameter.
Microvascular oxygen distribution. The PO 2 distribution in arterioles, venules, and tissue is shown in Fig. 6 . Arteriolar PO 2 was not significantly different between groups after the level 3 exchange, being 19.5 Ϯ 4.6 mmHg for the control group and 16.5 Ϯ 4.2 mmHg for the PFC group. Venules had a significantly higher PO 2 in the control group (13.3 Ϯ 3.5 mmHg, P Ͻ 0.05) than in the PFC group (7.7 Ϯ 2.5 mmHg). After the increase of FI O 2 , the arterioles of the PFC group had a significant increase in PO 2 (42.7 Ϯ 9.7 mmHg, P Ͻ 0.05) compared with the control group. Venules did not change significantly in either group, but the difference between the control (14.1 Ϯ 2.5 mmHg, P Ͻ 0.05) and PFC groups (7.8 Ϯ 1.4 mmHg) was significant with 100% FI O 2 .
Tissue PO 2 was measured in 10 different locations in each preparation and was significantly higher in the PFC group (2.8 Ϯ 0.8 mmHg, n ϭ 80, P Ͻ 0.05) than in the control group (2.3 Ϯ 1.0 mmHg, n ϭ 78, P Ͻ 0.05) at level 3 exchange (see Fig. 6 ). Increasing FI O 2 caused tissue PO 2 to be significantly higher in the PFC group (3.2 Ϯ 0.9 mmHg, n ϭ 80, P Ͻ 0.05) than in the control group (2.8 Ϯ 1.1 mmHg, n ϭ 78, P Ͻ 0.05), Oxygen inspiration (100%) significantly increased arteriolar PO2 at level 3 hemodilution with PFC but had no effect on HES 200 hemodilution and 100% FIO 2 . Statistical significance in tissue oxygen levels is achieved as a consequence of the large number of measurements and the small SD; however, the small differences found are probably not important in a biological context. Values are presented as means Ϯ SD. There were significant changes in PO2. †Significant difference with change in FIO 2 (P Ͻ 0.05); ‡significantly different between fluids (P Ͻ 0.05).
both groups being significantly different compared with level 3 exchange. Tissue oxygen levels were significantly lower than in animals without hemodilution.
Oxygen delivery. Oxygen delivery was measured directly by combining systemic data of CO, carotid artery PO 2 , and blood composition ( Eqs. 2 and 3) . This parameter was significantly reduced after level 1 exchange relative to baseline in the control group to 75 Ϯ 4% (2.4 Ϯ 0.5 ml O 2 /min in control, P Ͻ 0.05). Level 2 and 3 exchange oxygen delivery was also reduced significantly relative to baseline in the control and PFC groups to 64 Ϯ 2% (2.0 Ϯ 0.1 ml O 2 /min in control, P Ͻ 0.05) and 24 Ϯ 1% (0.8 Ϯ 0.1 ml O 2 /min in control, P Ͻ 0.05) and 73 Ϯ 16% (2.0 Ϯ 0.2 ml O 2 /min with PFC, P Ͻ 0.05) and 26 Ϯ 5% (0.7 Ϯ 0.1 ml O 2 /min with PFC, P Ͻ 0.05), respectively. Increasing FI O 2 significantly lowered oxygen delivery compared with baseline in both groups to 32 Ϯ 1% (1.0 Ϯ 0.1 ml O 2 /min in control, P Ͻ 0.05) in the control group and 51 Ϯ 16% (1.4 Ϯ 0.2 ml O 2 /min with PFC, P Ͻ 0.05) in the PFC group, respectively (Fig. 7) .
Increasing FI O 2 significantly increased oxygen delivery in both the control and PFC groups, namely, to 134 Ϯ 5% for the control group (1.0 Ϯ 0.1 ml O 2 /min, P Ͻ 0.05) and 195 Ϯ 34% for the PFC group (1.4 Ϯ 0.2 ml O 2 /min, P Ͻ 0.05), respectively. Systemic oxygen delivery was 25% higher in the PFC group compared with the control group after FI O 2 was increased.
Tissue oxygen supply. The supply of oxygen to the tissue was measured after level 3 exchange in both groups and after the increase of FI O 2 , as shown in Fig. 8 
DISCUSSION
The principal finding of this study is that direct microvascular measurements show that the presence of a PFC emulsion in the circulation of an awake hemodiluted animal significantly increases local oxygen delivery and consumption with 100% normobaric oxygen inspiration compared with identically hemodiluted subjects with HES 200, also inspiring 100% oxygen. This result was further confirmed by systemic studies showing that in conditions of extreme hemodilution, there is a significantly greater whole body oxygen delivery (25%) in animals with the same amount of PFC solution in the circulation compared with animals only hemodiluted with HES 200, both groups inspiring 100% oxygen. In considering these results, it should be noted that they originate from calculations rather than from direct measurements and that as a consequence of the extreme hemodilution condition total oxygen delivery for both groups is still twofold less than baseline.
The present results also show that there is no significant difference between animals with and without PFC in the circulation, in terms of both systemic and microvascular parameters, in extreme hemodilution when breathing normobaric air. Thus it is appropriate to conclude that the extra oxygen delivery observed in the microcirculation during 100% oxygen inspiration is due to the presence of the PFCs in the circulation.
Our investigations were carried out using an extreme hemodilution protocol already tested in previous studies aimed at determining the efficacy of oxygen-carrying plasma expanders [Tsai et al. (30) ]. In our protocol, Hct was reduced to ϳ11% (Hb ϳ 3.5 g/dl), which is a value close to the critical Hct for this species, i.e., the Hct (or Hb concentration) beyond which further hemodilution places the animal in an oxygen supplydependent condition. At this level of hemodilution, in our experiments, the acid-base balance was negative and remained negative in control animals that were hemodiluted only with HES 200, even when they inspired 100% oxygen. Conversely, the acid-base balance returned to normal values in the animals treated with PFC breathing 100% oxygen. Furthermore, determinations of systemic oxygen delivery show that fluorocarbon caused a significant increase in the amount of oxygen transported and consumed (20) compared with the minimal increase due to the oxygen carried by plasma in the HES 200-treated group during 100% oxygen inspiration.
The effect of fluorocarbons on oxygen transport at 100% oxygen inspiration is also evident in the differences in CO because control (no PFC) animals did not increase CO upon inspiring 100% oxygen, whereas animals treated with PFC increased CO by 50% with the increased FI O 2 . Considering that a similar increase in oxygen delivery was found using microvascular data from the window chamber, it is plausible to assume that these microvascular observations may reflect changes occurring in other tissues.
This study shows that infusion of a 4.2 g/kg dose of PFC emulsion combined with 100% oxygen ventilation is well tolerated in all animals and has no negative effects on microvascular perfusion, a result also reported by Nolte et al. (17) . The increased oxygen delivery in the microcirculation found in this study is due to the increased arteriolar PO 2 . Venular PO 2 did not change, causing the arteriolar-venous difference across the microcirculation to increase. These two events, coupled with the maintenance of blood flow in the microcirculation and the increased oxygen-carrying capacity, caused oxygen delivery to increase substantially, and thus in this tissue and microvascular network the presence of fluorocarbon increases arteriolar PO 2 at 100% FI O 2 , increasing the amount of oxygen delivered by RBCs. Exposure to hyperoxia has been shown to cause vasoconstriction (23); however, there was no evidence for this effect in our investigations. This may be in part due to the high level of hemodilution to which the animals were subjected before breathing 100% oxygen. The negative acid-base balance suggests that the animals were borderline hypoxic, which is a stimulus for dilatation. Notably, the combination of circulating PFC and 100% inspired oxygen inspiration did restore the acid-base balance, suggesting that hypoxia was reversed and that hyperoxic inspiration did not cause vasoconstriction. As shown in several studies recently reviewed by Tsai et al. (29) , there is a continous exit of oxygen from both the circulation and microcirculation driven by the oxygen gradient between blood and tissue. In normal conditions for this species, this oxygen efflux determines that arteriolar PO 2 is in the range of 50 mmHg. In hemodilution, the initial arterial oxygen gradients are the same, and thus the magnitude of the efflux of oxygen, which solely depends on the gradient, is the same. However, the progressive depletion of oxygen from blood lowers its saturation, and therefore blood arriving to the microcirculation in extreme hemodilution has a significantly lower PO 2 .
The presence of PFC at 100% FI O 2 significantly increases the oxygen transported from the lungs to the major blood vessels. The intrinsically higher blood tissue oxygen gradient in these conditions could increase premicrocirculatory oxygen exit; however, this efflux is not sufficient to deplete the oxygen in blood, and in the present experiments arteriolar blood attains an approximately normal PO 2 . We found that both the control and PFC groups reached the same pre-100% FI O 2 inhalation venular PO 2 , suggesting that oxygen extraction in the PFC group is enhanced, an effect that may be due to the lowering of the diffusional resistance in the plasma layer by the presence of PFC particles, thus enhancing oxygen-unloading capacity.
Tissue oxygen supply with PFC was 0.7 ϫ 10 Ϫ7 and 4.2 ϫ 10 Ϫ7 ml O 2 /s for normoxia and hyperoxia, respectively, and was significantly lower in both groups compared with baseline on an identical animal preparation (23) , where it was 33.7 ϫ 10 Ϫ7 ml O 2 /s for normoxia and 34.1 ϫ 10 Ϫ7 ml O 2 /s for hyperoxia.
A critical parameter that is a determinant of microvascular function is FCD, which was not different between control and PFC-infused animals nor between normoxic and hyperoxic ventilation. The drop of FCD in extreme hemodilution in both hypoxia and hyperoxic conditions is probably a consequence of the low blood viscosity, as proposed by Tsai and Intaglietta (27) , who indicated that there is a need for a threshold capillary pressure to maintain capillaries sufficiently distended to allow for the passage of RBCs. However, in all conditions, FCD ranged to 60 -65% of control, a value that is low, but not pathological, according to the findings of Kerger et al. (14) and Tsai et al. (26) , who determined that microvascular function is compromised when FCD drops below 40% of control.
Fluorocarbons have been tested for their ability to transport oxygen in various experimental conditions and even clinical trials, and analysis of their effectiveness at the cellular level was usually based on determining whether tissue PO 2 is improved by the presence of PFCs in the circulation and 100% FI O 2 (7). In our study, tissue PO 2 increased significantly from a statistical view point; however, the increase is in all probability not physiologically important for tissue oxygenation. The low values found in our experiments, even with 100% FI O 2 , may be a characteristic of the tissue studied and that we could measure tissue PO 2 in areas between microvessels. In this situation, measurements are not affected by the diffusion field from arterioles, an effect likely to be present when using larger electrodes that prevent identifying the location of measurement.
The lack of evidence of vasoconstriction with PFC perfusion and 100% FI O 2 may in part be due to the increased blood and plasma viscosity caused by PFC relative to that attained with HES 200 hemodilution. Increased plasma viscosity in hemodilution produces a vasodilatory stimulus and the enhancement of microvascular function (26) , an effect that may be due to the increased production of vasodilators such as nitric oxide and prostacyclin by the endothelium (6).
In conclusion, this study shows that the presence of a 4.2 g/kg dose of PFC emulsion and ventilation with 100% oxygen in animals that have undergone extreme hemodilution to a Hct of 11% reverses the consequences of anoxia present when PFC is not present in the circulation. Our findings demonstrate that PFCs are able to deliver oxygen to the tissue when combined with hyperoxic ventilation. Furthermore, in the extreme hemodilution protocol followed in this study, hyperoxic ventilation and PFC administration gave no evidence of impaired microvascular function. Our results show that PFCs and hyperoxia restore microvascular and systemic functionality in extreme hemodilution, a finding that may not necessarily be obtained with lesser degrees of Hct reductions, which were not explored in this study. However, systemic and microvascular improvements found in the conditions of the present experiments exceed those attainable with hyperoxia and conventional plasma expanders.
